Skip to main content

Table 8 Secondary outcome measures

From: Pilot parallel randomised controlled trial of protective socks against usual care to reduce skin tears in high risk people: ‘STOPCUTS’

 

Socks group: percent completion, mean and (s.d.) or median and (IQR). N = 44

TAU group: percent completion, mean and (s.d.) or median and (IQR). N = 46

Measure

Completion (%)

Mean (sd)

Median (IQR)

Baseline

After injury (n = 10)

At 16 weeks

Change from baseline to 16 weeks

Baseline

After injury (n = 13)

At 16 weeks

Change from baseline to 16 weeks

EQ5D mobility

100%

100%

86.4%

 

100%

61.9%

89.1%

 

3.09 1.25)

3.10 (1.37

2.74 (1.31)

− 0.35

2.83 (1.36)

2.38 (1.12)

2.56 (1.31)

− 0.27

3.5 (2)

3.5 (2)

3.0 (3)

− 0.5

3.0 (2)

2.0 (2)

3.0 (3)

0

EQ5D self-care

100%

100%

84.1%

 

100%

61.9%

87%

 

2.2 (1.44)

1.04 (1.62)

2.05 (1.37)

− 0.15

2.46 (1.66)

1.62 (0.87)

2.10 (1.46)

− 0.36

2.0 (2)

1.5 (3)

1.0 (2)

− 1.0

2.0 (3)

1.0 (2)

1.0 (2)

− 1.0

EQ5D usual activities

100%

100%

86.4%

 

97.8%

61.9%

87%.

 

2.64 (1.45)

3.0 (1.70)

2.54 (1.45)

− 0.1

2.31 (1.31)

2.08 (1.12)

2.35 (1.44)

0.04

2.0 (3)

3.0 (4)

2.0 (3)

0

2.0 (2)

2.0 (2)

2.0 (2)

0

EQ5D pain/discomfort

100%

100%

86.4%

 

100%

61.9%

89.1%

 

2.14 (1.07)

1.80 (1.03)

1.95 (1.01)

− 0.19

1.96 (0.89)

1.38 (0.77)

1.90 (0.94)

− 0.06

2.0 (2)

1.5 (1)

2.0 (2)

0

2.0 (2)

1.0 (1)

2.0 (2)

0

EQ5D anxiety/depression

100%

100%

86.4%

 

97.8%

61.9%

89.1%

 

1.3 (0.63)

1.3 (0.48)

1.50 (0.76)

0.2

1.57 (0.86)

1.31 (0.48)

1.41 (0.81)

− 0.16

1.0 (0)

1.0 (1)

1.0 (1)

0

1.0 (1)

1.0 (1)

1.0 (1)

0

EQ5D utility score

100%

100%

84.1%

 

95.7%

61.9%

87%

 

0.664 (0.234)

0.649 (0.204)

0.695 (0.227)

0.031

0.673 (0.262)

0.808 (0.186)

0.731 (0.246)

0.058

EQ5D health state

84.1%

60%

65.9%

 

87%

52.4%

65.2%

 

62.62 (21.45)

63.33 (12.52)

68.66 (17.01)

6.04

67.58 (23.35)

71.45 (22.05)

69.77 (22.03)

2.19

EQ5D health state box

90.9%

90%

81.8%

 

91.3%

61.9%

82.6%

 

62.63 (21.56)

64.44 (12.36)

71.53 (20.18)

8.9

67.50 (23.12)

73.08 (21.07)

70.13 (21.2)

2.63

ICECAP

100%

100%

100%

 

86.4%

61.9%

89.1%

 

0.737 (0.419)

0.6359 (0.2514)

0.811 (0.285)

0.074

0.767 (0.310)

0.7107 (0.2395)

0.788 (0.309)

0.021

FES

100%

100%

86.4%

 

100%

61.9%

89.1%

 

14.25 (6.16)

14.7 (5.27)

14.24 (6.31)

 

12.98 (5.44)

14.08 (6.78)

13.29 (6.52)

 

13 (8.5)

14 (10.5)

14 (10.25)

1

11(6)

11 (11)

10 (10)

− 1.0

CWIS physical symptoms and daily living/120

N/a

100%

50%

 

N/a

61.9%

70%

 

N/a

28.7 (14.85)

26.25 (4.5)

− 2.45

N/a

26.62 (9.2)

32.0 (8.35)

5.38

N/a

24.5 (18)

24 (6.8)

− 0.5

N/a

28 (12.5)

30 (4)

2.0

CWIS social life/70

N/a

100%

50%

 

N/a

61.9%

70%

 

N/a

15.8 (13.59)

15.0 (2.0)

− 0.8

N/a

15.54 (5.75)

18.0 (6.51)

2.46

N/a

7.5 (18.75)

14 (3)

6.5

N/a

15 (4.5)

15 (6)

0

CWIS wellbeing/35 (high score is worse)

N/a

90%

75%

 

N/a

61.9%

70%

 

N/a

11.26 (4.73)

10.67 (4.32)

− 0.59

N/a

15.84 (4.45)

17.14 (5.15)

1.3

N/a

15 (7)

9.5 (7.25)

− 5.5

N/a

17 (8)

18 (5)

1.0

CWIS quality of life/20 (high score is better)

N/a

100%

62.5%

 

N/a

61.9%

70%

 

N/a

13.5 (3.95)

11.8 (4.03)

− 1.7

N/a

15.15 (3.21)

12.43 (6.19)

− 2.72

N/a

14.5 (3.5)

14 (8)

− 0.5

N/a

16 (5.5)

14 (13)

− 2.0